| 
May 26, 2023
Aurora Cannabis falls 2.49 cents as trading session draws to a close around the 53.51 cents level.
Core Durable Goods Orders in United States fell short of market expectations (0%) with a reading of -0.2%, continuing the decline from the previous figure of 0.3%. Highly important Pending Home Sales data from United States beat analyst expectations of 0.5% with a reading of 0%.
Meanwhile, United States Core PCE Price Index (MoM) (Apr) released today at 12:30 UTC with a figure of 0.4, while the previous figure was 0.3.
Aurora Cannabis Inc. pushed below the 54.0967 cents support level and extended 1 cents beyond it. The MACD index is indicating that momentum is shifting from bullish to bearish following a negative crossover. When the MACD falls below the signal line, it is typically considered to be a bearish development favoring short positions. Aurora Cannabis has just crossed the lower Bollinger Band® at 53.6559 cents, indicating further losses could be forthcoming.
Looking forward, Aurora Cannabis is poised to extend its strong downtrend and continue declining.
Aurora Cannabis's stock value drop coincides with Medtronic is down to $81.47, losing 2.48%, after ending yesterday at $83.54. After closing the previous session (yesterday) at $64.56, Bristol-Myers Squibb Company lost 70 cents and is trading around $63.86.
Positive performances can be seen by looking at other health care stocks as Astrazeneca PLC is up 1.09%.
The Canadian cannabis spearhead is now trading 79.49% below the significant high of $2.73 it set around a year ago.
